181 related articles for article (PubMed ID: 19762323)
1. [Hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC): evaluation, prevention and policies to avoid occupational exposure for operating room personnel].
Simon L; Halilou MC; Gladieff L; Gadiou M; Herin F; Hennebelle I; Chatelut E; Ferron G
Bull Cancer; 2009 Oct; 96(10):971-7. PubMed ID: 19762323
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of environmental contamination by platinum and exposure risks for healthcare workers during a heated intraperitoneal perioperative chemotherapy (HIPEC) procedure.
Konate A; Poupon J; Villa A; Garnier R; Hasni-Pichard H; Mezzaroba D; Fernandez G; Pocard M
J Surg Oncol; 2011 Jan; 103(1):6-9. PubMed ID: 20886552
[TBL] [Abstract][Full Text] [Related]
3. [Occupational Health Aspects of Pressurised Intraperitoneal Aerosol Chemotherapy (PIPAC): Confirmation of Harmlessness].
Oyais A; Solass W; Zieren J; Reymond MA; Giger-Pabst U
Zentralbl Chir; 2016 Aug; 141(4):421-4. PubMed ID: 24497166
[No Abstract] [Full Text] [Related]
4. Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion.
González-Bayón L; González-Moreno S; Ortega-Pérez G
Eur J Surg Oncol; 2006 Aug; 32(6):619-24. PubMed ID: 16672186
[TBL] [Abstract][Full Text] [Related]
5. Hyperthermic intraperitoneal chemotherapy: methodology and safety considerations.
González-Moreno S; González-Bayón L; Ortega-Pérez G
Surg Oncol Clin N Am; 2012 Oct; 21(4):543-57. PubMed ID: 23021715
[TBL] [Abstract][Full Text] [Related]
6. Low surface contamination by cis/oxaliplatin during hyperthermic intraperitoneal chemotherapy (HIPEC).
Schierl R; Novotna J; Piso P; Böhlandt A; Nowak D
Eur J Surg Oncol; 2012 Jan; 38(1):88-94. PubMed ID: 22035874
[TBL] [Abstract][Full Text] [Related]
7. Techniques and Safety Issues for Intraperitoneal Chemotherapy.
González-Moreno S; Ortega-Pérez G; Alonso-Casado O; Galipienzo-García J; Linero-Noguera MJ; Salvatierra-Díaz D
Surg Oncol Clin N Am; 2018 Jul; 27(3):495-506. PubMed ID: 29935685
[TBL] [Abstract][Full Text] [Related]
8. Treatment-related morbidity and toxicity of CRS and oxaliplatin-based HIPEC compared to a mitomycin and doxorubicin-based HIPEC protocol in patients with peritoneal carcinomatosis: a matched-pair analysis.
Glockzin G; von Breitenbuch P; Schlitt HJ; Piso P
J Surg Oncol; 2013 May; 107(6):574-8. PubMed ID: 22833286
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of peritoneal carcinomatosis with surgery and hyperthermic peroperative intraperitoneal chemotherapy (HIPEC): new aspects and validated indications].
Eveno C; Dagois S; Guillot E; Gornet JM; Pocard M
Bull Cancer; 2008 Jan; 95(1):141-5. PubMed ID: 18230580
[TBL] [Abstract][Full Text] [Related]
10. Occupational exposure to cisplatin/oxaliplatin during Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC)?
Ametsbichler P; Böhlandt A; Nowak D; Schierl R
Eur J Surg Oncol; 2018 Nov; 44(11):1793-1799. PubMed ID: 29871821
[TBL] [Abstract][Full Text] [Related]
11. Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C.
Schmid K; Boettcher MI; Pelz JO; Meyer T; Korinth G; Angerer J; Drexler H
Eur J Surg Oncol; 2006 Dec; 32(10):1222-5. PubMed ID: 16784832
[TBL] [Abstract][Full Text] [Related]
12. Hyperthermic intraperitoneal perfusion chemotherapy--views on the observed variability in oxaliplatin pharmacokinetics.
Srinivas NR
Eur J Clin Pharmacol; 2009 Mar; 65(3):321-2. PubMed ID: 19011850
[No Abstract] [Full Text] [Related]
13. Occupational exposure to platinum drugs during intraperitoneal chemotherapy. Biomonitoring and surface contamination.
Ndaw S; Hanser O; Kenepekian V; Vidal M; Melczer M; Remy A; Robert A; Bakrin N
Toxicol Lett; 2018 Dec; 298():171-176. PubMed ID: 29852276
[TBL] [Abstract][Full Text] [Related]
14. Optimization of hyperthermic intraperitoneal chemotherapy with oxaliplatin plus irinotecan at 43 degrees C after compete cytoreductive surgery: mortality and morbidity in 106 consecutive patients.
Elias D; Goere D; Blot F; Billard V; Pocard M; Kohneh-Shahri N; Raynard B
Ann Surg Oncol; 2007 Jun; 14(6):1818-24. PubMed ID: 17356950
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cisplatin in semi-closed hyperthermic peritoneal perfusion (HPP) for treatment of peritoneal carcinomatosis.
Cattel L; De Simone M; Passera R; Verlengo MC; Delprino L
Anticancer Res; 2004; 24(3b):2041-5. PubMed ID: 15274398
[TBL] [Abstract][Full Text] [Related]
16. Current status and future directions in the treatment of peritoneal dissemination from colorectal carcinoma.
Elias D; Quenet F; Goéré D
Surg Oncol Clin N Am; 2012 Oct; 21(4):611-23. PubMed ID: 23021719
[TBL] [Abstract][Full Text] [Related]
17. [Peritonectomy and intraperitoneal chemotherapy--new methods in multi-modality therapy of peritoneal carcinosis].
Jähne J; Piso P
Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():1435-7. PubMed ID: 9931904
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of oxaliplatin exposure of healthcare workers during heated intraperitoneal perioperative chemotherapy (HIPEC).
Villa AF; El Balkhi S; Aboura R; Sageot H; Hasni-Pichard H; Pocard M; Elias D; Joly N; Payen D; Blot F; Poupon J; Garnier R
Ind Health; 2015; 53(1):28-37. PubMed ID: 25327298
[TBL] [Abstract][Full Text] [Related]
19. Peritoneal carcinomatosis treated with cytoreductive surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for advanced ovarian carcinoma: a French multicentre retrospective cohort study of 566 patients.
Bakrin N; Bereder JM; Decullier E; Classe JM; Msika S; Lorimier G; Abboud K; Meeus P; Ferron G; Quenet F; Marchal F; Gouy S; Morice P; Pomel C; Pocard M; Guyon F; Porcheron J; Glehen O;
Eur J Surg Oncol; 2013 Dec; 39(12):1435-43. PubMed ID: 24209430
[TBL] [Abstract][Full Text] [Related]
20. Routine second-look after surgical treatment of colonic peritoneal carcinomatosis.
Delhorme JB; Triki E; Romain B; Meyer N; Rohr S; Brigand C
J Visc Surg; 2015 Jun; 152(3):149-54. PubMed ID: 25650364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
